Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial.
Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial.
复制标题
DOI:
10.1016/j.cct.2018.02.001
复制
发表时间:
2018-04
影响因子:
2.2
通讯作者:
Coronado GD
中科院分区:
文献类型:
--
作者:
Thompson JH;Davis MM;Leo MC;Schneider JL;Smith DH;Petrik AF;Castillo M;Younger B;Coronado GD
Colon cancer is the second leading cause of cancer deaths in the United States. The Participatory Research to Advance Colon Cancer Prevention (PROMPT) study is a collaboration between two research institutions and a federally qualified health center (FQHC). The study seeks to raise colon cancer screening rates using a direct-mail fecal immunochemical testing (FIT) and reminder program in an FQHC serving a predominantly Latino population in California. PROMPT is a pragmatic trial enrolling 16 clinics. The study will test automated and live prompts (i.e., alerts, reminders) to a direct-mail FIT program in two phases. In Phase I, we tailored and defined intervention components for the pilot using a community-based participatory research approach called boot camp translation. We then plan to conduct a three-arm patient-randomized comparative effectiveness trial in two pilot clinics to compare 1) automated prompts, 2) live prompts, and 3) a combination of automated plus live prompts to alert and remind patients to complete screening. In Phase II, the adapted best practice intervention will be spread to additional clinics within the FQHC (estimated population 27,000) and assessed for effectiveness. Patient and staff interviews will be conducted to explore receptivity to the program and identify barriers to implementation. This pragmatic trial applies innovative approaches to engage diverse stakeholders and will test the effectiveness and spread of a direct-mail plus reminder program. If successful, the program will provide a model for a cost-effective method to raise colon cancer screening rates among Latino patients receiving care in FQHCs. National Clinical Trial (NCT) Identifier NCT03167125
登录
查看更多内容
影响因子:
3.8
作者:
Glasgow, RE;Klesges, LM;Estabrooks, P
通讯作者:
Estabrooks, P
影响因子:
2.4
作者:
Glasgow, Russell E.;Klesges, Lisa M.;Vogt, Thomas M.
通讯作者:
Vogt, Thomas M.
影响因子:
5.7
作者:
Goldman, Shira N.;Liss, David T.;Baker, David W.
通讯作者:
Baker, David W.
影响因子:
5.7
作者:
Coronado, Gloria D.;Rivelli, Jennifer S.;Jimenez, Ricardo
通讯作者:
Jimenez, Ricardo
影响因子:
4.2
作者:
Byrd, Theresa L.;Wilson, Katherine M.;Fernandez, Maria E.
通讯作者:
Fernandez, Maria E.